🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Florida › Orlando

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Orlando, FL keessatti

Qorannoo 12 Kansaar Onnee Triple-Negative f Orlando fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Advent Health, Orlando
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • AdventHealth Cancer Institute, Orlando
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06586957

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Namoota walitti qabaa jiraSadarkaa 3
  • Orlando Health Cancer Institute ( Site 0012), Orlando
  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Namoota walitti qabaa jiraSadarkaa 3
  • Orlando Health Cancer Institute ( Site 0030), Orlando
  • AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Sara Cannon Research Institute Lake Nona, Orlando
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05983432

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07020117

SMP-3124LP in Adults With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Advent Health, Celebration · Miili 17 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06526819

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Florida Cancer Specialists - Lake Nona, Orlando
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT06150664

A Study of LY4175408 in Participants With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07046923

Study of XB010 in Subjects With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06545331

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Namoota walitti qabaa jiraSadarkaa 1
  • Dren Investigational Site, Orlando
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06999187

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Orlando keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.